Hydrazones and analogs as cholesterol lowering agents
AssigneeTularik Inc.
InventorsJulio C. Medina, Hirohiko Hasegawa
Life of this patent
Estimating the term…
Abstract
Hydrazones and hydrazone analogs are provided which are useful as upregulators of LDL receptors and can be used in the treatment of hypercholesterolemia and related disorders and conditions.
Claims60
A compound having the formula (I):
- 31
- wherein
- the subscript n is an integer of from 1 to 2;
- the lowercase letters d and e are each independently selected from the group consisting of CH and N;
- Q is selected from the group consisting of Ar1 C(R1)═N— and
- 32
- wherein Ar1 is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, R1 is H or substituted or unsubstituted (C1-C4)alkyl, the lowercase letters a, b and c are each independently CH or N, each Z1 is independently selected from hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine, and the subscript
- m is an integer of from 1 to 4;
- W is a member selected from the group consisting of NH, O, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
- X is a member selected from the group consisting of S and —CH═CH—;
- Y is a member selected from the group consisting of —CO2R′, —CH2OR′, —C(O)R′, —C(O)NR′R″ and —CH2NR′R″, wherein R′ and R″ are each members independently selected from the group consisting of hydrogen and (C1-C8)alkyl;
- and
- each Z2 is a member independently selected from the group consisting of hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine.
A composition comprising a pharmaceutically acceptable excipient and a compound having the formula (I):
- 37
- wherein
- the subscript nI is an integer of from 1 to 2;
- the lowercase letters d and e are each independently selected from the group consisting of CH and N;
- Q is selected fr om the group consisting of Ar1C(R1)═N— and
- 38
- wherein Ar1 is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, R1 is H or substituted or unsubstituted (C1-C4)alkyl, the lowercase letters a, b and c are each independently CH or N, each Z1 is independently selected from hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine, and the subscript
- m is an integer of from 1 to 4;
- W is a member selected from the group consisting of NH, O, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
- X is a member selected from the group consisting of S and —CH═CH—;
- Y is a member selected from the group consisting of —CO2R′, —CH2OR′, —C(O)R′, —C(O)NR′R″ and —CH2NR′R″, wherein R′ and R″ are each members independently selected from the group consisting of hydrogen and (C1-C8)alkyl;
- and
- each Z2 is a member independently selected from the group consisting of hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine.
A method of treating a disease or condition selected from the group consisting of hypercholesterolemia, hyperlipidemia and other metabolic disorders associated with abnormally high levels of lipoproteins, cholesterol or triglycerides, said method comprising administering to a subject in need of such treatment an effective amount of a compound having the formula (I):
- 43
- wherein
- the subscript n is an integer of from 1 to 2;
- the lowercase letters d and e are each independently selected from the group consisting of CH and N;
- Q is selected from the group consisting of Ar1 C(R1)═N— and
- 44
- wherein Ar1 is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, R1 is H or substituted or unsubstituted (C1-C4)alkyl, the lowercase letters a, b and c are each independently CH or N, each Z1 is independently selected from hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine, and the subscript m is an integer of from 1 to 4;
- W is a member selected from the group consisting of NH, O, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
- X is a member selected from the group consisting of S and —CH═CH—;
- Y is a member selected from the group consisting of —CO2R′, —CH2OR′, —C(O)R′, —C(O)NR′R″ and —CH2NR′R″, wherein R′ and R″ are each members independently selected from the group consisting of hydrogen and (C1-C8)alkyl;
- and
- each Z2 is a member independently selected from the group consisting of hydroxy, halogen, amino, nitro, cyano, substituted or unsubstituted monocyclic heterocycloalkyl, substituted or unsubstituted (C1-C10)alkyl, substituted or unsubstituted (C1-C10)alkoxy, substituted or unsubstituted benzyloxy, substituted or unsubstituted (C1-C8)acylamine, substituted or unsubstituted (C1-C8)alkylamine and substituted or unsubstituted di(C1-C8)alkylamine.
Dependencies are inferred from the claim text.